DC Chemicals · Product datasheet

Ostarine(MK-2286) — Datasheet

CAT. NO. DC8248

Product page and current package options

ParameterValue
Chemical NameOstarine
CAS No.841205-47-8
Synonyms(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide;Ostarine;(S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide;MK-2866;MK-2866 (GTx-024);MK-2866 (Ostarine);Ostarine NOT FOR SAL;Ostarine NOT FOR SALE-PATENTED;OSTARINE(MK-2866);MK2866;Enobosarm;Enobosarmum;(2S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide (ACI);GTx 024;MK 2866;SARM S-22;V 024;V-024
FormulaC19H14F3N3O3
M.Wt389.327974796295
SMILESC(C1C=C(NC(=O)[C@](O)(C)COC2C=CC(C#N)=CC=2)C=CC=1C#N)(F)(F)F
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Ostarine(MK-2866; GTX-024) is a modulator of human androgen receptor.IC50 value:Target: androgen receptorOstarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation